• About us
• Contact

Advertisement

Product › Details

regulatory services

	Next higher product group	legal services

Record changed: 2025-01-04

Advertisement

More documents for regulatory services

• [1] Evotec SE. (12/11/24). "Press Release: Evotec SE Announces First Projects for LAB eN² Drug Discovery Accelerator with Novo Nordisk". Pratteln....
• [2] BioNTech SE. (8/22/24). "Press Release: Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine". New York, NY & Mainz....
• [3] Good Dog Food Ltd. (d/b/a Meatly). (7/10/24). "Press Release: World-First Regulatory Approval. Meatly Becomes First Ever European Company Authorised to Sell Cultivated Meat, Following UK Clearance for Its Cultivated Pet Food"....
• [4] Pfizer Inc.. (4/26/24). "Press Release: U.S. FDA Approves Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B". New York, NY....
• [5] Valneva S.E.. (10/25/23). "Press Release: Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment". Saint Herblain....
• [6] AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne....
• [7] QbD Group. (5/25/23). "Press Release: The QbD Group Acquires Michor Consulting to Enhance Its Regulatory Affairs Services across Europe"....
• [8] CRISPR Therapeutics AG. (4/3/23). "Press Release: CRISPR Therapeutics and Vertex Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for Exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalas...
• [9] ADC Therapeutics S.A.. (12/21/22). "Press Release: ADC Therapeutics and Sobi Announce European Commission Approval of Zynlonta (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma". Lausanne....
• [10] Atara Biotherapeutics, Inc.. (12/19/22). "Press Release: Atara Biotherapeutics’ Ebvallo (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD". Thousand Oaks, CA & Castres....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.